JA - Standards Development for Regenerative Medicine Therapies

Inactive
Notice ID:FDA-JA-1224405

JA for FDA-INT-1224405 per attachment "FDA-JA-1224405 CBER_OTAT Regenerative Medicine Therapies".

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   OTHER SPECIAL STUDIES AND ANALYSES


Data sourced from SAM.gov. View Official Posting »